Teva Pharmaceutical Industries Ltd officer Mark Sabag sells $1.93M in stock
The officer sold at an average of $41.93 a share, according to a Form 4 filed with the SEC on Nov 6.
Mark Sabag, an officer of Teva Pharmaceutical Industries Ltd (TEVA), sold 46,000 shares on Nov 5 at an average price of $41.93, a total of about $1.9 million, according to a Form 4 filed with the SEC on Nov 6.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The trade was reported within two business days, as Section 16 requires.
The insider still holds 80,760 shares after the sale, 36% fewer than before.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Teva Pharmaceutical Industries Ltd (TEVA) |
|---|---|
| Insider | Mark Sabag |
| Role | Officer |
| Transaction | Open-market sale (code S) |
| Shares | 46,000 |
| Average price | $41.93 |
| Value | $1,928,729 |
| Trade date | Nov 5, 2026 |
| Filed with the SEC | Nov 6, 2026, 4:03 PM ET |
| Shares held after | 80,760 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
View this Form 4 in Insider Stock Trader
See more large insider sales · See the biggest insider trades of each day
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
